Aprogen Medicines Inc. (KRX:007460)

Market Cap	218.30B
Revenue (ttm)	150.11B
Net Income (ttm)	-58.08B
Shares Out	291.07M
EPS (ttm)	-225.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,158,652
Average Volume	1,953,541
Open	757.00
Previous Close	756.00
Day's Range	755.00 - 799.00
52-Week Range	710.00 - 1,891.00
Beta	0.85
RSI	47.41
Earnings Date	Mar 20, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 245
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.